Twelve-Month Results of a Single or Multiple Dexamethasone Intravitreal Implant for Macular Edema following Uncomplicated Phacoemulsification

Table 1

Patient characteristics and best corrected visual acuity (BCVA) values in study eye using ETDRS charts prior to treatment and at follow-up intervals.

Patient	Gender	Age	Baseline	Day 7	Mo. 1	Mo. 2	Mo. 4	Mo. 6	Mo. 8	Mo. 12
1	F	72	78	84	86	87	88	88	88	88
2	F	81	71	73	78	79	80	80	80	80
3	M	78	36	58	70	78	—	—	—	—
4	M	77	35	36	73	78	49	36	—	—
5	F	78	70	71	73	74	76	78	83	84
6^*	M	81	65	80	83	84	75	66	78	65
7^*	F	62	72	74	80	83	76	70	80	78
8^*	F	65	59	60	70	73	68	67	72	74
9^*	M	71	60	78	80	83	67	62	83	75
10^*	M	71	70	79	83	83	75	68	84	88
Mean		73.6	61.6	69.3	77.6	80.2	72.7	68.3	81	79
Median		74.5	67.5	73.5	79	81	75	68	81.5	79
SD		6.5	14.9	14.4	5.8	4.5	10.8	14.6	4.8	7.8
Range		62–81	35–78	36–84	70–86	73–87	49–88	36–88	72–88	65–8
value^†				0.005	0.005	0.005	0.008	0.084	0.011	0.018
Delta^‡				7.7	16	18.6	11.1	6.7	19.4	17.4

Patients denoted with had a second implant at month 7.
Patients dropped out from the study.
^† value refers to Wilcoxon signed-rank test on the median values with respect to the baseline.
^‡Delta denotes the mean difference with the baseline.
Mo.: month.